13Nov
Covid–19 coronavirus: global merger review (updated 13 November 2020)
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). The table below reflects our understanding of the current effects on the merger review process in numerous jurisdictions around the world. It...
By:
Allen & Overy LLP
Related
The Resolution of the President of the Republic of Uzbekistan No. PP-4422 dated August 22, 2019, (Th...
Read More >
In a recent article published in The New York Times, Jason Dana, a professor at the Yale School of M...
Read More >
Recently issued proposed regulations clarify changes made by the TCJA to the tax deductibility of ex...
Read More >
James Hanson, Managing Director with Opportune Partners LLC, discusses why fairness and solvency opi...
Read More >
On May 21, 2020, the Securities and Exchange Commission announced rule and form amendments that will...
Read More >
Workplace vaccination programs are not new. While many focus on influenza, healthcare employers ofte...
Read More >